LCID
Lucid Group, Inc.
LCID lost money over the past year, so it has no meaningful PE right now. Analysts expect losses to shrink, though they disagree widely on how much.
ROLR
High Roller Technologies, Inc.
There isn't enough reported data to score ROLR yet.
LCID Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
LCID's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
ROLR Fundamentals
| Metric | Status |
|---|---|
| Weak | |
| Under pressure | |
| Weak | |
| Unavailable |
ROLR's revenue, profitability and cash flow are currently under pressure. There isn't enough data to rate its balance sheet.
LCID PE Valuation
LCID has no meaningful PE right now: it lost money over the past year.
ROLR PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 8.6x | $3.26 | — |
| Cheap | 12x | $4.47 | +37% |
| Fair | 14x | $5.49 | +69% |
| Expensive | 22x | $8.28 | +154% |
Historical ranges are pointers, not guarantees.
ROLR's PE is 8.6x, but its earnings don't support one, so it isn't a reliable read right now.
LCID Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect LCID's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
ROLR Forward outlook
There aren't enough analyst estimates for ROLR to show an outlook.
LCID Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$13.08 | -$2.57 |
| Q2 2026 | -$13.65 | -$2.35 |
| Q1 2026 | -$13.15 | -$1.25 |
| Q4 2025 | -$12.09 | +$0.41 |
| Q3 2025 | -$10.51 | +$2.49 |
| Q2 2025 | -$11.30 | +$0.40 |
| Q1 2025 | -$11.90 | +$0.40 |
| Q4 2024 | -$12.50 | +$1.10 |
LCID is still losing money, but less than at its worst: $13.08 per share over the past year, against $16.50 at its worst in mid-2023.
ROLR Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | $0.38 | +$1.21 |
| Q1 2026 | $0.53 | +$1.47 |
| Q4 2025 | $0.33 | +$1.10 |
| Q3 2025 | -$0.37 | +$0.31 |
| Q2 2025 | -$0.83 | -$0.19 |
| Q1 2025 | -$0.94 | -$0.40 |
| Q4 2024 | -$0.77 | -$0.43 |
| Q3 2024 | -$0.68 | -$0.46 |
ROLR has the edge over LCID on earnings quality, reporting a profit while its opponent remains loss making.
LCID Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $350.3M | +4.1% |
| Q2 2026 | $405.3M | +56% |
| Q1 2026 | $282.5M | +20% |
| Q4 2025 | $522.7M | +123% |
| Q3 2025 | $336.6M | +68% |
| Q2 2025 | $259.4M | +29% |
| Q1 2025 | $235M | +36% |
| Q4 2024 | $234.5M | +49% |
LCID has the edge over ROLR on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -245% | +35 points |
| Q2 2026 | -267% | +43 points |
| Q1 2026 | -350% | -56 points |
| Q4 2025 | -204% | +109 points |
| Q3 2025 | -280% | +105 points |
| Q2 2025 | -310% | +83 points |
| Q1 2025 | -294% | +128 points |
| Q4 2024 | -313% | +156 points |
LCID's operating margin was −245% last quarter, up 35 points from the same quarter a year ago, near the top of its range since 2020.
ROLR Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $2.8M | -60% |
| Q1 2026 | $3.4M | -50% |
| Q4 2025 | $465K | -94% |
| Q3 2025 | $6.3M | -16% |
| Q2 2025 | $6.9M | +20% |
| Q1 2025 | $6.8M | +4.1% |
| Q4 2024 | $8.1M | +12% |
| Q3 2024 | $7.5M | -0.7% |
ROLR's revenue has slid since its 2024 peak: $3M last quarter, down 60% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -88% | -81 points |
| Q1 2026 | -59% | -12 points |
| Q4 2025 | -547% | -522 points |
| Q3 2025 | 1.3% | +7.6 points |
| Q2 2025 | -7.2% | +18 points |
| Q1 2025 | -47% | -19 points |
| Q4 2024 | -25% | -0.9 points |
| Q3 2024 | -6.3% | -3.9 points |
ROLR has the edge over LCID on profitability, with a higher operating margin.
LCID Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1B | -$84.2M |
| Q2 2026 | -$1.5B | -$463.2M |
| Q1 2026 | -$1.4B | -$849M |
| Q4 2025 | -$1.2B | -$417.1M |
| Q3 2025 | -$955.5M | -$333M |
| Q2 2025 | -$1B | -$271.6M |
| Q1 2025 | -$589.9M | +$125.1M |
| Q4 2024 | -$824.8M | -$77.6M |
LCID has burned cash in almost every quarter: −$5.2B over the past year, against −$3.4B the year before.
ROLR Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$2.9M | -$2M |
| Q1 2026 | -$3M | +$629K |
| Q4 2025 | $1.3M | +$3.8M |
| Q2 2025 | -$845K | +$115K |
| Q1 2025 | -$3.6M | -$3.2M |
| Q4 2024 | -$2.6M | -$2.5M |
| Q2 2024 | -$960K | -210% |
| Q1 2024 | -$412K | +$11.5K |
ROLR has the edge over LCID on cash flow, with more consistent year-over-year improvement.
LCID Net Leverage
LCID's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
ROLR Net Leverage
LCID Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.9 | Neutral |
| Stochastic | 7.1 | Oversold |
LCID's weekly RSI is 33 (neutral) and its Stochastic is 7 (oversold).
ROLR Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 37.2 | Neutral |
| Stochastic | 5.2 | Oversold |
ROLR's weekly RSI is 37 (neutral) and its Stochastic is 5 (oversold).
LCID PE vs Consumer Cyclical Sector
LCID has no meaningful PE right now: it lost money over the past year.
ROLR PE vs Consumer Cyclical Sector
| Metric | ROLR | Sector median | Relative |
|---|---|---|---|
| PE | 8.6x | 18x | 52% below |
| PE % | 3 | 20 | 17 pts below |
ROLR is trading at 8.6x earnings, a 52% discount to the Consumer Cyclical sector's median of 18x, though its earnings don't support one.
LCID Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.53 | 7.9% below |
| 20 week MA | $4.88 | 33% below |
| 50 week MA | $7.33 | 56% below |
| 100 week MA | $15.4 | 79% below |
| 200 week MA | $31.9 | 90% below |
ROLR has stronger trend alignment. LCID is above 0 of 5 weekly averages versus ROLR above 0 of 4.
ROLR Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $4.40 | 26% below |
| 20 week MA | $5.47 | 40% below |
| 50 week MA | $5.34 | 39% below |
| 100 week MA | $4.25 | 23% below |
ROLR is in a downtrend: it's below all four of its weekly moving averages, and 23% below its 100-week average.
LCID Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $98.9 | $100.4 | +1.5% |
| 2021 | $100.4 | $376.4 | +275% |
| 2022 | $376.4 | $67.0 | -82% |
| 2023 | $67.0 | $42.1 | -37% |
| 2024 | $42.1 | $32.0 | -24% |
| 2025 | $32.0 | $11.4 | -64% |
| 2026 YTD | $11.4 | $3.25 | -72% |
LCID has finished four years in a row lower, and it's down 72% so far in 2026.
ROLR Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2024 | $7.75 | $4.28 | -45% |
| 2025 | $4.28 | $1.41 | -67% |
| 2026 YTD | $1.41 | $3.26 | +131% |
ROLR has the edge over LCID on returns for 2026, with the stronger performance.